Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Sickle Cell Disease (Adults)

Management of Surgical Patients

Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy.

Aziz AM, Meshikhes AW.

Source‎: JSLS 2011;15(4):480-5.

Indexed‎: PubMed 22643502

DOI‎: 10.4293/108680811X13176785203996

Impact of hydroxyurea on perioperative management and outcomes in children with sickle cell anemia.

Hayashi M, Calatroni A, Herzberg B, Ross AK, Rice HE, Thornburg C.

Source‎: J Pediatr Hematol Oncol 2011;33(7):487-90.

Indexed‎: PubMed 21941139

DOI‎: 10.1097/MPH.0b013e318230b2f4

Tourniquet use during total knee replacement in a Jehovah’s Witness with sickle cell trait: a case report.

Siddiqui FM, Slater RM, Razzaq I, Atkinson M, Ryan K.

Source‎: Eur J Anaesthesiol 2010;27(6):581-2.

Indexed‎: PubMed 20299991

DOI‎: 10.1097/EJA.0b013e328334f16e

Acute normovolemic hemodilution in sickle cell patient–a case report.

Abu Zeid HA, Al-Ghamdi A, Al Nafea AN.

Source‎: Middle East J Anesthesiol 2009;20(3):465-8.

Indexed‎: PubMed 19950747

Erythropoietin therapy for sickle cell anemia in Jehovah’s Witnesses.

Brooks BJ Jr, Hanson DS, Cryer PA, Hubbard WJ, Hooper D.

Source‎: South Med J 1991;84(11):1416-7.

Indexed‎: PubMed 1948247

Hydroxycarbamide and erythropoietin in the preoperative management of children with sickle cell anaemia undergoing moderate risk surgery.

Furness CL, O'Driscoll S, Davenport M, Morrison G, Height SE, Dick MC, Rees DC.

Source‎: Br J Haematol 2009;144(3):453-4.

Indexed‎: PubMed 19036093

DOI‎: 10.1111/j.1365-2141.2008.07463.x

A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy.

Leff DR, Kaura T, Agarwal T, Davies SC, Howard J, Chang AC.

Source‎: Surg Endosc 2007;21(7):1117-21.

Indexed‎: PubMed 17180280

Minor elective surgical procedures using general anesthesia in children with sickle cell anemia without pre-operative blood transfusion.

Fu T, Corrigan NJ, Quinn CT, Rogers ZR, Buchanan GR.

Source‎: Pediatr Blood Cancer 2005;45(1):43-7.

Indexed‎: PubMed 15880471

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.